Quantcast

Latest Epratuzumab Stories

2010-11-09 07:05:00

ATLANTA, Nov. 9, 2010 /PRNewswire/ -- UCB (EURONEXT: UCB) and U.S. based partner Immunomedics Inc.

2010-06-16 08:30:00

ATLANTA, June 16 /PRNewswire-FirstCall/ -- UCB (Euronext: UCB) and Immunomedics, Inc. (Nasdaq: IMMU) announced new lupus drug candidate, epratuzumab, provided a significant reduction in disease activity in patients with moderate to severe active systemic lupus erythematosus (SLE).

2008-11-11 09:00:47

MORRIS PLAINS, N.J., Nov. 11, 2008 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that Gerard G.

2008-10-14 09:00:11

MORRIS PLAINS, N.J., Oct. 14, 2008 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, announced that U.S.

2008-09-08 09:00:52

MORRIS PLAINS, N.J., Sept. 8, 2008 (GLOBE NEWSWIRE) -- Immunomedics, Inc.

2008-08-01 12:00:28

MORRIS PLAINS, N.J., Aug. 1, 2008 (PRIME NEWSWIRE) -- Immunomedics, Inc.

2008-06-18 09:00:00

NEW ORLEANS, June 18, 2008 (PRIME NEWSWIRE) -- Immunomedics, Inc.

2008-06-17 15:01:05

NEW ORLEANS, June 17, 2008 (PRIME NEWSWIRE) -- Immunomedics, Inc.

2008-06-16 12:00:00

NEW ORLEANS, La., June 16, 2008 (PRIME NEWSWIRE) -- Immunomedics, Inc.


Word of the Day
swell-mobsman
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.